Reid Laurence bought MGX

September 9, 2026 · Form 4 insider transaction

Reid Laurence bought 117 shares of Metagenomi Therapeutics, Inc. at $1.18 per share, a transaction worth $138.06. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.